Delivering
Next Generation
Therapeutics

 
jake-sloop-238656.jpg

Gene Therapy
Delivered

CRISPR/Cas9 is a powerful genome editing tool that makes therapeutic gene editing possible. It is easier to use, faster, and more accurate than previous gene editing techniques and thus has the potential for a wide range of therapeutic applications.

GenEdit is developing non-viral delivery technologies for the CRISPR/Cas9 gene editing system that can safely and efficiently correct gene mutations in patients.

More about us

New Era of Genome Editing

CRISPR/Cas9 is a powerful genome editing tool that makes therapeutic gene editing possible. It is easier to use, faster, and more accurate than previous gene editing techniques and thus has the potential for a wide range of therapeutic applications.

home_genome_v3.jpg
 

We solve
the biggest challenge
for CRISPR therapeutics

DSC_8244.jpg

CRISPR
Delivery vehicle
& Engineering

CRISPR/Cas9 gene editing has the potential to treat a variety of incurable genetic diseases. However, developing therapeutics based on the CRISPR system has been challenging because of delivery problems.

GenEdit has developed a new delivery vehicle for CRISPR/Cas9 therapeutics, which can encapsulate Cas9 protein, guide RNA, and donor DNA, into a single nanoparticle for safe and efficient genome editing . 

We also work on engineering of core components of CRISPR/Cas9 genome editing system to increase editing efficiency and enable targeted delivery. 

More about our science

 

home_vehicle_v10.jpg

News

GenEdit's core technologies have been published in top science journals - Nature Materials and Nature Biomedical Engineering - and featured in science news media. 

 

FierceBiotech_2_bnw.jpg

The biggest challenge of CRISPR/Cas9 field is a delivery problem. GenEdit provides a new approach solving the problem with safe and efficient technology.

cen_4_bnw.jpg

CRISPR-Gold, nonviral nanoparticle delivery for CRISPR, developed by GenEdit is made up of gold nanoparticles combined with DNA. 

sciencemag_3_bnw.jpg

Researchers have found a way to deliver gene-activating molecules called transcription factors into specific tissues of a living animal for the first time.